The relaxin hormone is involved in the variety of biological functions in normal tissues and diseases. The role of relaxin is well-established in female reproduction and parturition, mammary gland and endometrial development, maintenance of myometrial quiescence during pregnancy. Relaxin signaling through its G protein-coupled receptor (GPCR) RXFP1 results in ECM remodeling through regulation of collagen deposition, cell invasiveness, proliferation and overall tissue homeostasis. Significantly, the therapeutic effects of relaxin in the treatment of renal, cardiac, skin, lung fibrosis, inflammation, and wound healing in animal models are well-established. Recombinant human relaxin (rhRlx) is currently being tested in clinical trials as a protective agent in congestive heart failure, in treating severe preeclampsia, and as an anti-fibrotic agent in systemic sclerosis. Upon relaxin binding RXFP1 activation leads to the activation of adenylate cyclase (AC) via Gs. cAMP will activate PKA, which phosphorylates many signaling proteins. Thus, detection of cAMP increase is an easy and reliable indication of relaxin receptor activation. To screen for agonists of the relaxin receptor, a THP1 cell line stably transfected with RXFP1 was used. RXFP1 activation was assayed by changes in cAMP levels as detected with a time-resolved fluorescence energy transfer (TR-FRET) cAMP detection kit. This is a cell-based assay for cAMP second messenger response to screen for agonists of the RXFP1 receptor. The assay was conducted in the presence of a PDE4 inhibitor (Ro 20174). The cells were lysed and the cAMP levels were measured with a TR-FRET cAMP kit. Presence of cAMP in the cell lysate disrupts binding between the cryptate-labeled anti-cAMP and d2-labeled cAMP pair, leading to a decrease in the TR-FRET signal. Data were normalized to the controls for basal activity (buffer only) and 100% activity (29 nM porcine relaxin). The EC50 values were determined from concentration-response data modeled with the standard Hill equation 1536-well assay protocol for the THP1 RXFP1 cAMP assay: (1) Add 3 ul THP1 RXFP1 cell culture. 2000 cells/well in DMEM/F12, 10% FBS, 1x Pen/Strep (dispensed offline with MultiDrop Combi). (2) Incubate 16-24 hr at 37C, 5% CO2. (3) Add 1 ul 400uM Ro20174 in DPBS, 0.05% BSA, 0.005% Tween 20. (3) Add 23 nl compounds in DMSO solution. Final concentration was 0.5 - 58 uM. (4) Incubate 30 min at 37C, 5% CO2. (5) Add 1 ul cAMP-d2 in lysis buffer (HTRF cAMP HiRange kit, CisBio). (6) Add 1 ul anti-cAMP antibody-cryptate in lysis buffer (HTRF cAMP HiRange kit, CisBio). (7) Incubate 30 min at room temperature. (6) Detect the assay plate in a ViewLux plate reader (PerkinElmer) with Ex=320 nm, Em1=615 nm and Em2=665 nm.
bao:BAO_0000540 "2676" ; # "is confirmatory assay of" -> "2676"
bao:BAO_0000812 "2703" ; # "has summary assay" -> "2703"
bao:BAO_0000809 bao:BAO_0000030 ; # "has confirmatory assay" -> "confirmatory assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_0000650 ; # "is bioassay type of" -> "cAMP redistribution assay"
bao:BAO_0000212 bao:BAO_0000123 ; # "has assay method" -> "binding assessment method"
bao:BAO_0000212 bao:BAO_0000129 ; # "has assay method" -> "immunoassay"
bao:BAO_0000207 bao:BAO_0000004 ; # "has detection method" -> "time resolved fluorescence resonance energy transfer"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Agonists of the Relaxin Receptor RXFP1" ; # "screening campaign name" -> "Agonists of the Relaxin Receptor RXFP1"
bao:BAO_0002853 "qHTS Assay for Agonists of the Relaxin Receptor RXFP1: THP1 Hit Validation" ; # "has assay title" -> "qHTS Assay for Agonists of the Relaxin Receptor RXFP1: THP1 Hit Validation"
bao:BAO_0002854 bao:BAO_0000010 ; # "has bioassay type" -> "functional"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0002863 bao:BAO_0000535 ; # "has concentration throughput" -> "multiple concentration"
bao:BAO_0000109 "37 degree celsius" ; # "has temperature value" -> "37 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "25 degree celsius" ; # "substrate incubation temperature" -> "25 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "30 minute" ; # "substrate incubation time" -> "30 minute"
bao:BAO_0002833 "30 minute" ; # "has incubation time value" -> "30 minute"
bao:BAO_0002857 "Porcine relaxin 29 nanomolar" ; # "has signal direction" -> "Porcine relaxin 29 nanomolar"
bao:BAO_0000740 bao:BAO_0000156 ; # "has assay control" -> "high signal control" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35225> ; # "has role" -> "buffer"
bao:BAO_0000740 bao:BAO_0000168 ; # "has assay control" -> "low signal control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Alexander I. Agoulnik" ; # "material entity assay provider" -> "Alexander I. Agoulnik" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BAO_0002739 "\"D2-labeled cAMP, HTRF acceptor fluorophore D2\"" ; # "has substrate" -> ""D2-labeled cAMP, HTRF acceptor fluorophore D2"" || bao:BAO_0003102 bao:BAO_0002030 ; # "has role" -> "coupled substrate"
bao:BA0_0090012 bao:BAO_0001038 ; # "has participant" -> "Tween 20" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_27780> ; # "has role" -> "detergent"
bao:BAO_0002000 bao:BAO_0001012 ; # "has measured entity" -> "Ro 20-1724" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35222> ; # "has role" -> "inhibitor"
bao:BA0_0090012 "Relaxin receptor 1" ; # "has participant" -> "Relaxin receptor 1"
bao:BAO_0002004 <http://purl.obolibrary.org/obo/CLO_0009348> ; # "has cell line" -> "THP-1 cell"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Q9HBX9" ; # "uniprot ID" -> "Q9HBX9"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% fetal bovine serum" ; # "material entity culture serum" -> "10% fetal bovine serum" || bao:BAO_0003102 bao:BAO_0002596 ; # "has role" -> "culture serum"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"DMEM/F12 with 10% FBS, 1x Pen/Strep\"" ; # "material entity culture medium" -> ""DMEM/F12 with 10% FBS, 1x Pen/Strep"" || bao:BAO_0003102 bao:BAO_0000114 ; # "has role" -> "culture medium"
bao:BAO_0002922 "\"DPBS/F12 with 10% FBS, 1x Pen/Strep\"" ; # "has assay medium" -> ""DPBS/F12 with 10% FBS, 1x Pen/Strep""
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "0.05% bovine serum albumin" ; # "material entity assay serum" -> "0.05% bovine serum albumin"
bao:BAO_0002923 bao:BAO_0002597 ; # "has assay serum" -> "assay serum"
bao:BAO_0000212 bao:BAO_0000246 ; # "has assay method" -> "stable transfection"
bao:BAO_0000550 "Expressing the relaxin/insulin-like family peptide receptor 1 (RXFP1)" ; # "DNA construct" -> "Expressing the relaxin/insulin-like family peptide receptor 1 (RXFP1)"
bao:BAO_0003105 "relaxin/insulin-like family peptide receptor 1" ; # "has function" -> "relaxin/insulin-like family peptide receptor 1"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "59350" ; # "construct gene ID" -> "59350"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BAO_0000502 "\"Europium Eu3+ cryptate-labeled anti-cAMP, HTRF fluorophore donor, Cisbio\"" ; # "antibody" -> ""Europium Eu3+ cryptate-labeled anti-cAMP, HTRF fluorophore donor, Cisbio""
bao:BA0_0090012 bao:BAO_0000875 ; # "has participant" -> "Cyclic adenosine monophosphate"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BAO_0000308 bao:BAO_0000938 ; # "has assay kit" -> "HTRF cAMP HiRange Detection Kit"
bao:BAO_0000308 bao:BAO_0000248 ; # "has assay kit" -> "assay Kit"
bao:BAO_0000737 bao:BAO_0000881 ; # "has manufacturer" -> "Cisbio" || bao:BAO_0003102 bao:BAO_0002626 ; # "has role" -> "biologics and screening manufacturer"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0000648 bao:BAO_0000733 ; # "compound library" -> "MLSMR library"
bao:BAO_0002865 bao:BAO_0000691 ; # "uses detection instrument" -> "ViewLux ultraHTS Microplate Imager"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "320 nanometer" ; # "has excitation wavelength value" -> "320 nanometer"
bao:BAO_0002918 "615 nanometer" ; # "has emission wavelength value" -> "615 nanometer"
bao:BAO_0002918 "665 nanometer" ; # "has emission wavelength value" -> "665 nanometer"
bao:BAO_0000208 bao:BAO_0000186 ; # "has endpoint" -> "AC50"
bao:BAO_0000337 bao:BAO_0000656 ; # "has percent response" -> "efficacy"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "3" ; # "PubChem TID" -> "3"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002787 "26" ; # "has concentration-point number" -> "26"
bao:BAO_0000196 bao:BAO_0000087 ; # "has mode of action" -> "activation"
bao:BAO_0002864 bao:BAO_0000533 ; # "has repetition throughput" -> "multiple repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
